
|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission
Author(s)Michael E. Thase, MD
Advertisement
Articles in this issue
about 24 years ago
Participating Facultyabout 24 years ago
Introductionabout 24 years ago
The Pharmacoeconomics of Venlafaxine in DepressionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Survey Reveals Clinician Confidence Around Using AI in PA Process
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5